How SARS-CoV-2 evolved to counter its own weaknesses | Hub
Hopkins researchers say their research can improve our understanding of how the spike protein works and how the virus evolves| The Hub
Hopkins researchers say their research can improve our understanding of how the spike protein works and how the virus evolves| The Hub
The newly available COVID-19 boosters offer the best protection against current strains. But who needs it and when should they get it?| The Hub
New booster shots designed to target the omicron variant and its subvariants, and the original strain of SARS-CoV-2, could become available in the U.S. in the coming weeks| The Hub
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19. Vaccine expert William Moss discusses its strengths and weaknesses ahead of its potential emergency use authorization.| The Hub
Johns Hopkins health security expert Tom Inglesby provides an update on the state of the pandemic and how vaccination, funding, and variants may affect its future| The Hub
Experts say the tragic milestone, now recorded by the Coronavirus Resource Center tracker, likely occurred months ago and that higher vaccination rates could have prevented many fatalities| The Hub
The CDC and FDA approved vaccines by Moderna and Pfizer/BioNTech in children older than 6 months; vaccinations began this week| The Hub
Certain antibodies isolated from people who had recovered from COVID-19 and were vaccinated have the ability to neutralize variety of coronaviruses| The Hub
Messages that emphasize vaccination within people's social groups shown to be more effective at reversing vaccine hesitancy than messages that highlight national vaccine statistics| The Hub
The first Johns Hopkins health care workers receive the COVID-19 vaccine, marking a turning point in the coronavirus pandemic| The Hub
Effective immediately, the change aligns with current federal public health guidelines| The Hub
Virtual assistant| The Hub
Vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks| The Hub
Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases| The Hub
